[
  {
    "ts": null,
    "headline": "Reasons to Add Cooper Companies Stock to Your Portfolio Now",
    "summary": "COO is riding premium MyDay lens momentum and margin expansion plans, but Asia-Pacific softness, tariffs and mix pressures pose near-term risks.",
    "url": "https://finnhub.io/api/news?id=b263b89f9d1de7ac831ee87ee531d5228b25bfbbeb2165b8a4192763354ab369",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770142620,
      "headline": "Reasons to Add Cooper Companies Stock to Your Portfolio Now",
      "id": 138345747,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "COO is riding premium MyDay lens momentum and margin expansion plans, but Asia-Pacific softness, tariffs and mix pressures pose near-term risks.",
      "url": "https://finnhub.io/api/news?id=b263b89f9d1de7ac831ee87ee531d5228b25bfbbeb2165b8a4192763354ab369"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet to Report Q4 Earnings: Here's What to Expect",
    "summary": "ZBH is set to report Q4 on Feb. 10, with revenues seen at $2.20B and EPS at $2.38 as hips, knees, robotics and S.E.T. drive growth estimates.",
    "url": "https://finnhub.io/api/news?id=4a24394d24c96a8b7783cf78892e2669a0d77cb80947688820dfca22710181d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770136680,
      "headline": "Zimmer Biomet to Report Q4 Earnings: Here's What to Expect",
      "id": 138345748,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "ZBH is set to report Q4 on Feb. 10, with revenues seen at $2.20B and EPS at $2.38 as hips, knees, robotics and S.E.T. drive growth estimates.",
      "url": "https://finnhub.io/api/news?id=4a24394d24c96a8b7783cf78892e2669a0d77cb80947688820dfca22710181d6"
    }
  },
  {
    "ts": null,
    "headline": "GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy?",
    "summary": "GEHC heads into fourth-quarter earnings with steady demand and strong product momentum, though tariffs and investments may keep margins in focus.",
    "url": "https://finnhub.io/api/news?id=bddd7464d832332ec7c9532c69b0def151bdf389d76b5f1098237bac33824f3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770136260,
      "headline": "GE HealthCare Stock Before Q4 Earnings: To Buy or Not to Buy?",
      "id": 138345749,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "GEHC heads into fourth-quarter earnings with steady demand and strong product momentum, though tariffs and investments may keep margins in focus.",
      "url": "https://finnhub.io/api/news?id=bddd7464d832332ec7c9532c69b0def151bdf389d76b5f1098237bac33824f3d"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights include Casey's General Stores, Brinker International, Cardinal Health and Flowserve",
    "summary": "Casey's General Stores leads a screen of stocks with strong coverage ratios, highlighting firms built to handle debt in a tighter market.",
    "url": "https://finnhub.io/api/news?id=b0094a83ada5b074703f8c79afd85eb2c32a7c4d22735c7956953e5d314fac53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770132720,
      "headline": "Zacks.com featured highlights include Casey's General Stores, Brinker International, Cardinal Health and Flowserve",
      "id": 138344369,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Casey's General Stores leads a screen of stocks with strong coverage ratios, highlighting firms built to handle debt in a tighter market.",
      "url": "https://finnhub.io/api/news?id=b0094a83ada5b074703f8c79afd85eb2c32a7c4d22735c7956953e5d314fac53"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy, Sell, or Hold McKesson Before Q3 Earnings?",
    "summary": "MCK approaches third-quarter earnings with strong growth expectations, but limited visibility on margins and investments keeps the outlook cautious.",
    "url": "https://finnhub.io/api/news?id=577940bab6cad1464b2acf08e35124df49ca4b2121f8458d7a566b6fafa12d30",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770128880,
      "headline": "Should You Buy, Sell, or Hold McKesson Before Q3 Earnings?",
      "id": 138344261,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "MCK approaches third-quarter earnings with strong growth expectations, but limited visibility on margins and investments keeps the outlook cautious.",
      "url": "https://finnhub.io/api/news?id=577940bab6cad1464b2acf08e35124df49ca4b2121f8458d7a566b6fafa12d30"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?",
    "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
    "url": "https://finnhub.io/api/news?id=035e414ebe69035849ceae308551549b7e88388136cc93f03666e9777e86f102",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770128105,
      "headline": "Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?",
      "id": 138344371,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
      "url": "https://finnhub.io/api/news?id=035e414ebe69035849ceae308551549b7e88388136cc93f03666e9777e86f102"
    }
  },
  {
    "ts": null,
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=408c3d198cfc3e5c4751fe4528f49be07dee0177f6d61caf88b2d89c909dd951",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770127204,
      "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
      "id": 138342850,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=408c3d198cfc3e5c4751fe4528f49be07dee0177f6d61caf88b2d89c909dd951"
    }
  }
]